0.7117

0.38% -0.0027

Kronos Bio Inc (KRON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.7144

Offen:

$0.7112

24-Stunden-Volumen:

1.03M

Relative Volume:

3.50

Marktkapitalisierung:

$51.88M

Einnahmen:

Nettoeinkommen (Verlust:

$-112.67M

KGV:

-0.365

EPS:

-1.95

Netto-Cashflow:

$-79.26M

1W Leistung:

-16.37%

1M Leistung:

-14.87%

6M Leistung:

-28.11%

1J Leistung:

-30.90%

1-Tages-Spanne:

$0.70

$0.725

1-Wochen-Bereich:

$0.67

$0.9299

52-Wochen-Spanne:

$0.67

$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Firmenname

Kronos Bio Inc

Sektor

Healthcare (1153)

Branche

Biotechnology (662)

Telefon

(650) 781-5200

Adresse

1300 S. EL CAMINO REAL, SAN MATEO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

KRON's Discussions on Twitter

Vergleichen Sie KRON mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KRON Kronos Bio Inc	0.7117	51.88M	0	-112.67M	-79.26M	-1.95
VRTX Vertex Pharmaceuticals Inc	499.82	126.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	609.40	65.06B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	648.47	37.54B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	258.99	32.56B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	255.31	26.40B	3.81B	-644.79M	-669.77M	-6.24

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-14	Herabstufung	Piper Sandler	Overweight → Neutral
2024-11-14	Herabstufung	TD Cowen	Buy → Hold
2022-09-14	Eingeleitet	Berenberg	Buy
2021-10-20	Fortgesetzt	Cowen	Outperform
2021-06-24	Eingeleitet	H.C. Wainwright	Buy
2020-11-03	Eingeleitet	Cowen	Outperform
2020-11-03	Eingeleitet	Goldman	Buy
2020-11-03	Eingeleitet	Jefferies	Buy
2020-11-03	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Kronos Bio Inc Aktie (KRON) Neueste Nachrichten

09:50 AM

Kronos shares slump on Concentra takeover news - The Pharma Letter

09:50 AM

May 01, 2025

Kronos Bio (KRON) to Merge with Concentra Biosciences in $0.57 P - GuruFocus

May 01, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kronos Bio, Inc.KRON - PR Newswire

May 01, 2025

Struggling Peninsula biotech with Gilead lineage is latest purchase for activist investor - The Business Journals

May 01, 2025

Now Is The Time To Build A Position In Kronos Bio Inc (NASDAQ:KRON) - Marketing Sentinel

May 01, 2025

KRON’s Stock Market Labyrinth: Navigating 2023’s Gains and Declines - investchronicle.com

May 01, 2025

Kronos Bio Enters Deal to be Acquired by Concentra Biosciences; Shares Fall - marketscreener.com

May 01, 2025

Today’s watch list includes Kronos Bio Inc (NASDAQ:KRON) stock - uspostnews.com

May 01, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (NasdaqKRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancor - Morningstar

May 01, 2025

Kronos Bio stock hits 52-week low at $0.68 amid market challenges - Investing.com India

May 01, 2025

After hunt for alternatives, Kronos Bio selects Tang Capital’s Concentra for a deal - Endpoints News

May 01, 2025

Kronos Bio (KRON) to be Acquired by Concentra Biosciences in Strategic Merger | KRON Stock News - GuruFocus

May 01, 2025

Shareholder Alert: The Ademi Firm Investigates Whether Kronos Bio, Inc. is Obtaining a Fair Price for Its Public Shareholders - Bluefield Daily Telegraph

May 01, 2025

KRON Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kronos Bio, Inc. Is Fair to Shareholders - The Joplin Globe

May 01, 2025

Concentra To Acquire Kronos Bio - Nasdaq

May 01, 2025

Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right - The Manila Times

May 01, 2025

Kronos Bio agrees to Concentra Biosciences acquisition - Investing.com

May 01, 2025

Kronos Bio Enters into Agreement to Be Acquired by - GlobeNewswire

May 01, 2025

Kronos Bio (KRON) Projected to Announce Quarterly Earnings on Thursday - Defense World

May 01, 2025

Apr 30, 2025

Renaissance Technologies LLC Has $1.11 Million Position in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World

Apr 30, 2025

Apr 11, 2025

Kronos Bio ends lease early, pays $1.4 million settlement - Investing.com Australia

Apr 11, 2025

Apr 10, 2025

Kronos Bio ends lease early, pays $1.4 million settlement By Investing.com - Investing.com Canada

Apr 10, 2025

Kronos Bio Announces Lease Termination Agreement - TipRanks

Apr 10, 2025

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - The Manila Times

Apr 10, 2025

Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025

Mar 26, 2025

Kronos Bio Reports 2024 Financial Results - TipRanks

Mar 26, 2025

Mar 25, 2025

Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 25, 2025

Mar 20, 2025

Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023) - Yahoo Finance

Mar 20, 2025

Mar 18, 2025

Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 18, 2025

Kronos Bio earnings missed by $0.17, revenue fell short of estimates - Investing.com Canada

Mar 18, 2025